Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002012675 | SCV002286148 | uncertain significance | Inherited glutathione synthetase deficiency | 2022-03-29 | criteria provided, single submitter | clinical testing | This sequence change results in a frameshift in the GSS gene (p.Tyr432Cysfs*62). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 43 amino acid(s) of the GSS protein and extend the protein by 18 additional amino acid residues. This variant is present in population databases (rs777065530, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with GSS-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002608094 | SCV003578978 | uncertain significance | Inborn genetic diseases | 2021-09-19 | criteria provided, single submitter | clinical testing | Not expected to trigger nonsense-mediated mRNA decay Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003491000 | SCV004235226 | uncertain significance | not provided | 2023-08-15 | criteria provided, single submitter | clinical testing |